Chest
-
Respiratory Support PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Non invasive ventilation (NIV) ia a technical support in patients with acute or chronic respiratory failure. The NIV is used in patients with obesity hypoventilation syndrome (OHS) presenting with hypercapnic respiratory failure. Few studies examine the evolution and impact after starting this therapy in this patient group Objectives: To evaluate the result of non invasive ventilation started in obese patients in acute hypercapnic respiratory failure (AHRF) and its prognosis consequences. Asses the impact of long-term NIVMETHODS: Observational study with consecutive inclusion of obese patients with AHRF treated with NIV from February 2008 to June 2011. Obesity: BMI>30kg/m; AHRF: pH<7.35 and PaCO2> 45mmHg. Treatment: NIV started in general or respiratory wards and emergency department ⋯ The following authors have nothing to disclose: Concepcion Romero, Jesús Sánchez, Virginia Almadana, Ana Gómez-Bastero, Patricia Guerrero, Agustin Valido, Jose María Benítez, Teodoro MontemayorNo Product/Research Disclosure Information.
-
Pulmonary and Sleep MedicineSESSION TYPE: Slide PresentationPRESENTED ON: Saturday, March 22, 2014 at 09:00 AM - 10:00 AMPURPOSE: Obstructive Sleep Apnea (OSA) affects at least 1-5% of middle aged individuals in various ethnic populations. The National Cholesterol Education program's Adult treatment panel III recognizes metabolic syndrome as multiple risk factor for Cardiovascular disease. The prevalence of Metabolic Syndrome is increasing with the epidemic of obesity. The presence of obesity to both Obstructive Sleep apnea and Metabolic Syndrome prompted several studies that aimed to establish relationship between OSA and Metabolic Syndrome. It is therefore the aim of this study to determine the association of Metabolic Syndrome and Obstructive Sleep Apnea among patients at the Philippine Heart Center. ⋯ The following authors have nothing to disclose: Cristito Alea, Aileen BanzonNo Product/Research Disclosure Information.
-
Clinical practice guidelines recommend enteral over parenteral nutrition in critical illness and do not recommend early initiation. Few data are available on parenteral nutrition use or timing of initiation in the ICU or how this use may have changed over time. ⋯ Use of parenteral nutrition in US ICUs declined from 2001 through 2008 in all patients and in all examined subgroups, with the majority of parenteral nutrition initiated within the first 7 days in ICU; enteral nutrition use coincidently increased over the same time period.
-
DVT/PE/Pulmonary HypertensionSESSION TYPE: Slide PresentationsPRESENTED ON: Sunday, March 23, 2014 at 12:15 PM - 01:15 PMPURPOSE: The long-term effect of riociguat was compared in patients with CTEPH in FC I/II versus FC III/IV at CHEST-1 baseline. ⋯ Andrea M D'Armini: Other Andrea D'Armini received fees for participation in review activities from Bayer: Hossein-Ardeschir Ghofrani: Grant monies (from industry related sources) Hossein-Ardeschir Ghofrani has received grant money paid to his institution by Bayer HealthCare: Friedrich Grimminger: Grant monies (from industry related sources) Friedrich Grimminger has received grant money paid to his institution by Bayer HealthCare: Marius M Hoeper: Consultant fee, speaker bureau, advisory committee, etc. Marius M. Hoeper has received consulting fees, honorarium and/or support for travel from Bayer: Pavel Jansa: Consultant fee, speaker bureau, advisory committee, etc. Pavel Jansa has received consulting fees, honorarium and/or support for travel to meetings from Bayer: Nick H Kim: Consultant fee, speaker bureau, advisory committee, etc. Nick H. Kim has received consulting fees, honorarium and/or support for travel to meetings from Bayer: Gerald Simonneau: Grant monies (from industry related sources) Gerald Simonneau has received grant money paid to his institution from Bayer: Adam Torbicki: University grant monies Adam Torbicki has received university grant monies for statute activities of the university: Martin Wilkins: Consultant fee, speaker bureau, advisory committee, etc. Martin Wilkins has received consulting fees, honorarium and/or support for travel to meetings from Bayer HealthCare: Arno Fritsch: Employee Arno Fritsch is a full-time employee of Bayer HealthCare: Neil Davie: Employee Neil Davie is a full-time employee of Bayer HealthCare: Eckhard Mayer: Consultant fee, speaker bureau, advisory committee, etc. Eckhard Mayer has received consulting fees, honorarium and/or support for travel to meetings from Bayer The following authors have nothing to disclose: Chen WangNo Product/Research Disclosure Information.
-
ILD Case Report Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Isolated extra-pulmonary manifestations of sarcoidosis occur in only 10% of cases. Exclusive splenic involvement is extremely rare; a review revealed only 5 prior cases reported in the literature. We report the case of a middle-aged female incidentally found to have splenomegaly on physical exam after presenting with non-specific constitutional symptoms. After extensive work-up, splenic resection confirmed sarcoidosis. One year follow-up revealed no development of pulmonary manifestations. ⋯ This case illustrates the importance of including sarcoidosis in the differential diagnosis of patients presenting with isolated splenomegaly and no pulmonary symptoms.Reference #1: Giovinale M, Fonnesu C, Soriano A, et al. European Review for Medical and Pharmacological Sciences 2009; 13(Suppl 1): 37-44.Reference #2: Zia H, Zemon H, Brody F. Journal of Laparoendoscopic & Advanced Surgical Techniques. April 2005, 15(2): 160-162.Reference #3: Warshauer DM, Lee JKT. AJR 2004; 182: 15-28DISCLOSURE: The following authors have nothing to disclose: Abhay Vakil, Hineshkumar Upadhyay, Khalid Sherani, Kelly Cervellione, Alan FeinNo Product/Research Disclosure Information.